AbbVie vows to keep drug price increases below 10 percent

FILE PHOTO - A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock ExchangeAbbVie Inc Chief Executive Richard Gonzalez on Wednesday promised to keep all drug price increases in 2017 under 10 percent, becoming the third global drugmaker to publicly make that pledge. Speaking at the annual JP Morgan Healthcare Conference in San Francisco, Gonzalez said his company would raise prices just once this year, and the percentage increases would not exceed single digits. AbbVie, whose rheumatoid arthritis treatment Humira is the world's biggest-selling drug, joins Allergan and Danish diabetes company Novo Nordisk as the first major drugmakers promising such a limit on price increases.

Source: Feed3

Leave a Reply

Your email address will not be published. Required fields are marked *